Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

ClinicalTrials.gov ID: NCT06824168

Public ClinicalTrials.gov record NCT06824168. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Open-label Trial to Evaluate Safety and Efficacy of Two Dose Levels of Quizartinib as Maintenance for Adult Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia in Complete Remission

Study identification

NCT ID: NCT06824168
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Daiichi Sankyo; Industry
Enrollment: 130 participants

Conditions and interventions

Conditions

Interventions

Quizartinib High Dose Drug
Quizartinib Low Dose Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 17, 2025
Primary completion: Jun 5, 2028
Completion: Jul 13, 2032
Last update posted: Jun 21, 2026

2025 – 2032

United States locations

U.S. sites: 9
U.S. states: 5
U.S. cities: 8

Facility	City	State	ZIP	Site status
John Hopkins School of Medicine	Baltimore	Maryland	21287	Not yet recruiting
Umass Memorial Health Care Systems	Worcester	Massachusetts	01655	Withdrawn
Roswell Park Cancer Institute	Buffalo	New York	14263	Withdrawn
Weill Cornell	New York	New York	10021-9800	Not yet recruiting
Westchester Medical College	Valhalla	New York	10595	Withdrawn
Clinical Research Allicance	Westbury	New York	11590	Not yet recruiting
Spoknwrd Clinical Trials Inc.	Easton	Pennsylvania	18045	Recruiting
The Methodist Hospital Research Institute	Houston	Texas	77030	Recruiting
The University of Texas MD Anderson Cancer Center	Houston	Texas	77030	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06824168, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 21, 2026 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06824168 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →